This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alvarez, M. Articles by Bidwell, J. Search for Related Content PubMed PubMed Citation Articles by Alvarez, M. Articles by Bidwell, J.

Rat Osteoblast and Osteosarcoma Nuclear Matrix Proteins Bind with Sequence Specificity to the Rat Type I Collagen Promoter¹

Department of Oral Biology (M.A., J.O.), and Department of Periodontics (J.H., W.X., J.B.), Indiana University School of Dentistry; Department of Medicine (H.L.), and Department of Anatomy (J.B.), Indiana University School of Medicine, Indianapolis, Indiana 46202; and Endocrinology (J.O., J.H.), Lilly Research Laboratories, Indianapolis, Indiana 46285

Address all correspondence and requests for reprints to: Joseph P. Bidwell, Indiana University School of Dentistry, DS235, 1121 West Michigan Street, Indianapolis, Indiana 46202. E-mail: jbidwell{at}iusd.iupui.edu

The nuclear matrix mediates the 3-dimensional organization of DNA and supports DNA replication and its transcription. We hypothesize that the osteoblast nuclear matrix contributes to the transcriptional control of type I collagen (COL1A1) expression. Cis-regulatory elements of the rat COL1A1 promoter that control osteoblast expression in vivo are between -2.3 and -1.67 kilobase pairs (kb) but lie within -3.5 and -2.3 kb in cultured bone cells. This may result from differences in cell architecture between osteoblasts in tissue and those in vitro. Our aim was to identify osteoblast nuclear matrix proteins (NMPs) that associated with sequence-specificity to the COL1A1 promoter. We used osteoblasts from the rat metaphyseal femur and the rat osteosarcoma cells, ROS 17/2.8. Nuclear matrix and soluble nuclear proteins were obtained as separate subfractions. Gel mobility shift analysis, using fragments of the COL1A1 promoter, was used to identify DNA-binding proteins in the nuclear subfractions. A NMP-DNA interaction, NMP3, was observed between -2149 and -2106 nucleotide in both osteoblasts and osteosarcoma cells. NMP4 was detected between -3518 to -3406 nucleotide. Therefore, osteoblast NMPs recognize sequences in regulatory regions of the COL1A1 promoter and may link cell structure and the transcriptional regulation of this protein.

This article has been cited by other articles:

				K. Cartharius, K. Frech, K. Grote, B. Klocke, M. Haltmeier, A. Klingenhoff, M. Frisch, M. Bayerlein, and T. Werner MatInspector and beyond: promoter analysis based on transcription factor binding sites Bioinformatics, July 1, 2005; 21(13): 2933 - 2942. [Abstract] [Full Text] [PDF]

				R. Shah, M. Alvarez, D. R. Jones, K. Torrungruang, A. J. Watt, N. Selvamurugan, N. C. Partridge, C. O. Quinn, F. M. Pavalko, S. J. Rhodes, et al. Nmp4/CIZ regulation of matrix metalloproteinase 13 (MMP-13) response to parathyroid hormone in osteoblasts Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E289 - E296. [Abstract] [Full Text] [PDF]

				K. Barseguian, B. Lutterbach, S. W. Hiebert, J. Nickerson, J. B. Lian, J. L. Stein, A. J. van Wijnen, and G. S. Stein Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins PNAS, November 26, 2002; 99(24): 15434 - 15439. [Abstract] [Full Text] [PDF]

				K. Torrungruang, M. Alvarez, R. Shah, J. E. Onyia, S. J. Rhodes, and J. P. Bidwell DNA Binding and Gene Activation Properties of the Nmp4 Nuclear Matrix Transcription Factors J. Biol. Chem., May 3, 2002; 277(18): 16153 - 16159. [Abstract] [Full Text] [PDF]

				Y. L. Ma, R. L. Cain, D. L. Halladay, X. Yang, Q. Zeng, R. R. Miles, S. Chandrasekhar, T. J. Martin, and J. E. Onyia Catabolic Effects of Continuous Human PTH (1-38) in Vivo Is Associated with Sustained Stimulation of RANKL and Inhibition of Osteoprotegerin and Gene-Associated Bone Formation Endocrinology, September 1, 2001; 142(9): 4047 - 4054. [Abstract] [Full Text] [PDF]

				R. R. Miles, J. P. Sluka, D. L. Halladay, R. F. Santerre, L. V. Hale, L. Bloem, K. Thirunavukkarasu, R. J. S. Galvin, J. M. Hock, and J. E. Onyia ADAMTS-1: A Cellular Disintegrin and Metalloprotease with Thrombospondin Motifs Is a Target for Parathyroid Hormone in Bone Endocrinology, December 1, 2000; 141(12): 4533 - 4542. [Abstract] [Full Text] [PDF]

				R. R. Miles, J. P. Sluka, R. F. Santerre, L. V. Hale, L. Bloem, G. Boguslawski, K. Thirunavukkarasu, J. M. Hock, and J. E. Onyia Dynamic Regulation of RGS2 in Bone: Potential New Insights into Parathyroid Hormone Signaling Mechanisms Endocrinology, January 1, 2000; 141(1): 28 - 36. [Abstract] [Full Text] [PDF]

				G. S. STEIN, A. J. VAN WIJNEN, J. L. STEIN, J. B. LIAN, S. H. POCKWINSE, and S. MCNEIL Implications for interrelationships between nuclear architecture and control of gene expression under microgravity conditions FASEB J, May 1, 1999; 13(9001): 157 - 166. [Abstract] [Full Text] [PDF]

				C. Zeng, S. McNeil, S. Pockwinse, J. Nickerson, L. Shopland, J. B. Lawrence, S. Penman, S. Hiebert, J. B. Lian, A. J. van Wijnen, et al. Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domains PNAS, February 17, 1998; 95(4): 1585 - 1589. [Abstract] [Full Text] [PDF]

				C. H. Thomas, J. H. Collier, C. S. Sfeir, and K. E. Healy Engineering gene expression and protein synthesis by modulation of nuclear shape PNAS, February 19, 2002; 99(4): 1972 - 1977. [Abstract] [Full Text] [PDF]